Clinical trial
Dose Escalation Of Icotinib In Previously Treated Patients With Routine Dose
NCT01465243
Study timeline
Study start (unknown)2011-09-01Date precision: month
Registry last updated2014-02-17
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Non-small Cell Lung Cancerunresolved
Interventions
IcotinibDRUG
Sponsors & collaborators
Betta Pharmaceuticals Co., Ltd.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01465243 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.